Penney Test (300887): Revenue performance is under pressure and waiting for demand to be released

Core view: Revenue performance in '23 and 24Q1 is under pressure, waiting for demand to be released. The company released the 2023 annual report and the 2024 quarterly report: the company achieved revenue of 2,468 billion yuan in 2023 (year-on-year - 34.4

廣發證券Apr 29 18:11

Penney Test (300887) Company Dynamics Research: Performance is under pressure in the short term; waiting for an upward inflection point

Event: Penney Test releases 2023 and 2024Q1 results: In 2023, the company achieved operating income of 2,468 billion yuan, a year-on-year decrease of 34.41%; realized net profit to mother of 108 million yuan, a year-on-year decrease of 6 million yuan

國海證券Apr 29 00:00

Penney Test (300887): Short-term medical tests affect performance growth, waiting for net interest rate to be repaired

Event: The company released its 2023 annual report and 2024 quarterly report. In 2023, the company achieved net profit of 108 million yuan, a year-on-year decrease of 67%, and the performance was close to the median forecast. 2024 Q1 Company Achievement

東吳證券Apr 26 11:36

Dongwu Securities released a research report on April 26 stating that it gave the Penney Test (300887.SZ) an increase in holdings rating. The main reasons for the rating include: 1) Affected by the medical sector, the short-term pressure on the growth rat

Dongwu Securities released a research report on April 26 stating that it gave the Penney Test (300887.SZ) an increase in holdings rating. The main reasons for the rating include: 1) Affected by the medical sector, the short-term pressure on the growth rate of performance; 2) gross margin was gradually restored, and the cost ratio returned to normal during the period; 3) endogenous and extrinsic expansion was carried out in combination, which is optimistic about the development prospects of leading testing companies. (Mainichi Keizai Shimbun)

Zhitong FinanceApr 26 11:03

Penney Test (300887) 2023 Report & 2024Q1 Quarterly Report Review: One-off impairment affects profit and expects profit recovery in 2024

Description of the event Penney Test releases its 2023 annual report and 2024Q1 quarterly report. In 2023, the company achieved revenue of 2,468 billion yuan, a year-on-year decrease of 34.41%; net profit to mother was 108 million yuan, a year-on-year decrease of 66.58 million yuan

長江證券Apr 24 18:26

Penney Test (300887): Impairment affects short-term performance and continues to build barriers to mergers and acquisitions

Introduction to this report: The company estimates that more than 140 million yuan of impairment will affect its 2023 performance, and subsequent impairment will have limited impact; the company will improve its performance structure through continuous mergers and acquisitions and build barriers to scale and management capacity, and the 2024 performance is expected to gradually increase

國泰君安Apr 24 16:36